The Thailand-based petroleum and chemicals producer will launch a joint venture with plastics trading platform operator in connection with a $19.4m investment.
Month: November 2018
Cochlear rests funding in Nyxoah’s account
The sleep disorder treatment developer has raised an additional $17.1m in a round led by medical device maker Cochlear.
Festicket books corporates for series D round
The music festival ticket marketplace plans to expand into North America and Asia having secured $10.5m from investors including Channel 4’s Commercial Growth Fund and InMotion Ventures.
C5 Capital identifies 4iQ for $18m investment
C5 Capital provided fresh funding for the identity-focused cybersecurity software provider, which raised $14m in a Telefónica-backed round two years ago.
SoftBank goes to WeWork with another $3bn
Work and living space provider WeWork will receive warrant financing from Vision Fund at a valuation of at least $42bn through two $1.5bn tranches in 2019.
Flyability lands $11m in series B funding
Swisscom Ventures co-led the indoor drone developer’s series B round, which also featured Dow Chemical and existing backers including MKS.
Telus goes for Panache
VC firm Panache Ventures has increased the target for its debut fund to approximately $38m after welcoming Telus Ventures as a limited partner.
Schneider Electric recharges corporate VC vehicle
The corporate has resurrected the Schneider Electric Ventures unit it folded into Aster in 2010 and will invest up to $565m through the vehicle.
Corporates help dish up $500m for iFood
Online food delivery platform iFood has secured another $500m in a round featuring majority owner Movile and fellow corporate Naspers.
Baidu lifts XinChao’s latest round to $302m
XinChao, the owner of a network of more than 700,000 elevator advertising screens, has secured funding in a round led by strategic partner Baidu.
NAB and US Bancorp reach Poynt for $100m
NAB and US Bancorp subsidiary Evalon invested in a series C round that increased payment technology developer Poynt’s overall funding to more than $130m.
Roivant revs up with $200m
Existing investors SoftBank Vision Fund and Dexxon both returned for a $200m round that will help drug developer Roivant Sciences expand its range of subsidiaries.
Amal Therapeutics amplifies series B round
Boehringer Ingelheim and Helsinn helped oncology vaccine developer Amal reach the second close of a series B round that now totals $32.7m.
XM Cyber secures $22m in series A funding
Nasdaq Ventures, Macquarie Capital and UST Global have helped cybersecurity technology developer XM Cyber close a series A round, bringing its total funding to $32m.